REFERENCES
- Sartori M, Semplicini A, Siffert W, Mormino P, Mazzer A, Pegoraro F, Mos L, Winnicki M and Palatini P. G-Protein β3-subunit gene 825T allele and hypertension : A longitudinal study in young grade I hypertensives. Hypertension 2003;42:909–914.
- Sato M, Soma M, Nakayama T and Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 2000;36:183–186.
- Jose PA, Eisner GM and Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol 2003;95:19–27.
- Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, Westerkamp J, Richart T, Thijs L, Li X, Brand-Herrman SM, Burnier M and Brand E. (2008) Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008;51:1643–1650.
- Beige J, Bellmann A, Sharma AM and Gessner R. Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens 2004;17:1184–1187.
- Chen B, Wilkening S, Drechsel M and Hemminki K. SNP_tools: A compact tool package for analysis and conversion genotype data for MS-Excel. BMC Res Notes 2009;2: 214.
- Zeng C, Felder RA and Jose PA. A new approach for treatment of hypertension: modifying D1 dopamine receptor function. Cardiovasc Hematol Agents Med Chem 2006;4: 369–377.
- Liu Q, Sobell JL, Heston LL and Sommer SS. Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics: identification of polymorphisms but lack of functionally significant sequence changes. Am J Med Genet 1995;60:165–171.